Cel
An ideal intervention in a chronic inflammatory disease such as Rheumatoid Arthritis (RA) would be a preventive one. In order to develop preventive strategies and therapies two key developments need to occur: (1) Biomarkers need to be identified that can be used to predict an individual’s risk of developing RA. (2) Modifiable disease mechanisms need to be identified and characterized in the early phases of disease. The key objective of the TEAM consortium is to specifically identify diagnostic biomarkers and disease mechanisms operating during the transition from health to rheumatoid arthritis. Our consortium will achieve this by developing a collaborative, integrated programme of work that links researchers with key SMEs involved in biomarker development to produce a “personalized predictive bioprofile” for patients destined to develop RA. The Euro-TEAM consortium will deliver a step change in the development of biomarkers and diagnostic kits that are timely, strategically important for European SMEs, and based on a disease (RA) in which concrete genetic and environmental risk factors have already been established. Firstly, it will directly compare biomarkers in the preclinical phases of disease with established markers in the clinical phases. Secondly, it will look beyond the synovium interrogating lymphoid, lung and periodontal tissue in a first-in-class approach to measuring systemic changes in the earliest phases of disease. Thirdly, it will place great emphasis on understanding why synovial inflammation resolves in some individuals and develop biomarkers of this “reverse” phase. Fourthly, it will explore a key cell type (stromal cells) that has been almost completely ignored in current biomarker studies. Finally, it will directly involve patients and other specialists, particularly from the fields of genetics, ethics and patient and public involvement in helping to visualize and communicate risk following a positive biomarker test.
Dziedzina nauki
Zaproszenie do składania wniosków
FP7-HEALTH-2012-INNOVATION-1
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-FP - Small or medium-scale focused research projectKoordynator
B15 2TT Birmingham
Zjednoczone Królestwo
Zobacz na mapie
Uczestnicy (15)
8006 ZURICH
Zobacz na mapie
2333 ZA Leiden
Zobacz na mapie
17177 Stockholm
Zobacz na mapie
1105AZ Amsterdam
Zobacz na mapie
1090 Wien
Zobacz na mapie
LS2 9JT Leeds
Zobacz na mapie
10117 Berlin
Zobacz na mapie
G12 8QQ Glasgow
Zobacz na mapie
91054 Erlangen
Zobacz na mapie
M13 9PL Manchester
Zobacz na mapie
100 44 Stockholm
Zobacz na mapie
Zakończenie uczestnictwa
1105 BA Amsterdam
Zobacz na mapie
55129 MAINZ
Zobacz na mapie
101 Reykjavik
Zobacz na mapie
751 05 Uppsala
Zobacz na mapie